- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: AZD9567
Total 75 results
-
AstraZenecaCompletedRheumatoid ArthritisGermany, United Kingdom
-
AstraZenecaCompletedCystic FibrosisSweden, Russian Federation, United Kingdom, Poland, Denmark, Germany
-
National Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Plasma Cell MyelomaUnited States
-
AstraZenecaCompletedRenal ImpairmentUnited States
-
AstraZenecaCompleted
-
AstraZenecaCompletedCancer | Advanced Solid MalignanciesJapan
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
AstraZenecaWithdrawnHealthy Male Subjects | Pharmacokinetics | Safety | Food EffectUnited Kingdom
-
AstraZenecaTerminatedCancer | Advanced Solid MalignanciesUnited States, Italy, United Kingdom, France, Germany, Spain, Netherlands
-
AstraZenecaParexelCompletedHealthy VolunteersUnited Kingdom
-
AstraZenecaQuotient SciencesCompletedCardiovascular DiseaseUnited Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany
-
Oxford University Hospitals NHS TrustUniversity of Oxford; Cancer Research UK; National Institute for Health Research...Completed
-
AstraZenecaCompletedBronchiectasisUnited Kingdom, Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Romania, Ukraine, Denmark, Netherlands, Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseKorea, Republic of, Poland, Germany, Philippines, Ukraine, Japan, United States, Australia, Canada, Slovakia, Taiwan, Russian Federation
-
Abbisko Therapeutics Co, LtdRecruitingUrothelial CarcinomaChina
-
AstraZenecaTerminated
-
AstraZenecaCompleted
-
AstraZenecaCompletedHealthy Subjects | Pharmacokinetics | Tolerability | SafetyUnited Kingdom
-
Abbisko Therapeutics Co, LtdCompleted
-
AstraZenecaTerminated
-
AstraZenecaParexelCompletedHealthy VolunteersUnited Kingdom
-
AstraZenecaParexelCompleted
-
AstraZenecaRecruitingNon-alcoholic Steatohepatitis (NASH)Austria, Germany, Sweden
-
AstraZenecaParexelCompletedNon-alcoholic SteatohepatitisUnited Kingdom
-
AstraZenecaCompleted
-
AstraZenecaCompletedRheumatoid ArthritisUnited Kingdom
-
AstraZenecaCompletedPharmacokineticsUnited Kingdom
-
AstraZenecaWithdrawnPharmacokinetics | PharmacodynamicsSweden
-
AstraZenecaCompletedHealthy VolunteerUnited Kingdom
-
AstraZenecaRecruitingCOVID-19 | SARS-CoV-2 InfectionUnited States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Bulgaria, Czech Republic, Poland, Hungary, Romania, Slovakia
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7 | FGFR1 Gene Amplification | FGFR2 Gene Amplification | FGFR2 Gene Mutation | FGFR3 Gene Mutation | FGFR1 Gene Mutation | FGFR3 Gene AmplificationUnited States, Canada
-
AstraZenecaCompletedRheumatoid ArthritisSweden, Netherlands
-
AstraZenecaParexelCompleted
-
AstraZenecaCompletedHealthy Subjects | PharmacodynamicsUnited Kingdom
-
AstraZenecaCompletedRheumatoid Arthritis | Healthy Subjects | Pharmacokinetics | Pharmacodynamics | Tolerability | SafetyGermany
-
AstraZenecaCompletedHeart Failure | Chronic Kidney DiseaseUnited States, Germany, Italy, Spain, Belgium, Denmark, Thailand, Poland, Canada, Korea, Republic of, Slovakia, Taiwan, Turkey, Ukraine, Japan, Czechia, Hungary, Bulgaria, Russian Federation, Sweden, Lithuania, India
-
Abbisko Therapeutics Co, LtdRecruitingUrothelial CarcinomaChina
-
AstraZenecaTerminatedGastric Cancer | Gastro-oesophageal Junction CancerBulgaria, Czech Republic, Italy, Korea, Republic of, Spain, United Kingdom, Hungary, Romania, Ukraine, Belgium, Canada, Germany, Taiwan, India, Japan, France
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)CompletedRecurrent Non-small Cell Lung Cancer | Squamous Cell Lung CancerUnited States
-
AstraZenecaTerminatedHeart FailureCzechia, Bulgaria, Poland, United Kingdom
-
AstraZenecaCompletedHealthy VolunteersGermany
-
M.D. Anderson Cancer CenterNovartisCompletedAcute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Agnogenic Myeloid MetaplasiaUnited States
-
AstraZenecaActive, not recruitingMuscle Invasive Bladder CancerSpain, United States, Canada, France, United Kingdom